1.
Weisser M, Kern W, Schoch C, Hiddemann W, Haferlach T, Schnittger S. Risk assessment by monitoring expression levels of partial tandem duplications in the MLL gene in acute myeloid leukemia during therapy. Haematologica [Internet]. 2005Jul.1 [cited 2026Nov.2];90(7):881-9. Available from: https://haematologica.org/article/view/3585